Suzanne Berlin

Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases

Journal of Allergy and Clinical Immunology · 2008 · 456 citations

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer

Journal of Clinical Oncology · 2009 · 238 citations